Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ginkgo Bioworks Hldgs Inc (DNA)

Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 532,586
  • Shares Outstanding, K 60,590
  • Annual Sales, $ 227,040 K
  • Annual Income, $ -547,030 K
  • EBIT $ -348 M
  • EBITDA $ -237 M
  • 60-Month Beta 1.55
  • Price/Sales 2.66
  • Price/Cash Flow N/A
  • Price/Book 0.94

Options Overview Details

View History
  • Implied Volatility 109.98% (+0.68%)
  • Historical Volatility 88.70%
  • IV Percentile 68%
  • IV Rank 49.50%
  • IV High 147.11% on 02/20/25
  • IV Low 73.59% on 06/20/25
  • Expected Move (DTE 7) 1.03 (11.70%)
  • Put/Call Vol Ratio 0.30
  • Today's Volume 318
  • Volume Avg (30-Day) 1,317
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 17,012
  • Open Int (30-Day) 29,701
  • Expected Range 7.76 to 9.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -1.80
  • Number of Estimates 1
  • High Estimate -1.80
  • Low Estimate -1.80
  • Prior Year -1.82
  • Growth Rate Est. (year over year) +1.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.73 +13.71%
on 02/05/26
11.10 -20.81%
on 01/22/26
-0.77 (-8.05%)
since 01/12/26
3-Month
7.36 +19.43%
on 11/18/25
11.10 -20.81%
on 01/22/26
+0.43 (+5.14%)
since 11/12/25
52-Week
5.00 +75.80%
on 04/04/25
17.58 -50.00%
on 10/08/25
-3.53 (-28.65%)
since 02/12/25

Most Recent Stories

More News
Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark

BOSTON , Feb. 5, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has demonstrated, in collaboration with OpenAI, an AI system that autonomously designed, executed, and learned...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

BOSTON , Jan. 13, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) announced today that Co-Founder and CEO Jason Kelly is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

BOSTON , Dec. 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Carnegie-Mellon University (CMU) for an award by the Advanced Research Projects Agency for...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment

Collaboration reduces time in fermenting complex bacterial strains, enabling continued focus on next-gen biological crop solutions.

DNA : 8.79 (-5.99%)
Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

BOSTON , Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project funded by the Advanced Research Projects Agency for Health...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC

BOSTON , Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National...

DNA : 8.79 (-5.99%)
STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene Therapy

CAMBRIDGE, Mass. , Dec. 3, 2025 /PRNewswire/ -- STRM.BIO, a start-up biotechnology company pioneering non-viral delivery technologies for in vivo cell and gene therapy, today announced that it...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health

BOSTON , Nov. 18, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with the Institute for Genomic Biology at the University of Illinois Urbana-Champaign on a five-year...

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Reports Third Quarter 2025 Financial Results

Ginkgo provides an update on its third quarter financial results

DNA : 8.79 (-5.99%)
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium

Ginkgo and Partners to Develop Monoclonal Antibody Biomanufacturing Innovations and to Produce an Anti-Filovirus Medical Countermeasure

DNA : 8.79 (-5.99%)

Business Summary

Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.

See More

Key Turning Points

3rd Resistance Point 10.03
2nd Resistance Point 9.72
1st Resistance Point 9.26
Last Price 8.79
1st Support Level 8.49
2nd Support Level 8.18
3rd Support Level 7.72

See More

52-Week High 17.58
Fibonacci 61.8% 12.77
Fibonacci 50% 11.29
Fibonacci 38.2% 9.81
Last Price 8.79
52-Week Low 5.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar